Adding deliberate fasting on top can push caloric intake dangerously low
less commonlyfatigue, headache, dizziness
Although patients receiving exenatide IR and experiencing longer durations of nausea and vomiting tended to lose more weight, those in the trial group who did not experience the gastrointestinal symptoms (70%) generally lost weight as well (166, 224)
They ask if you are currently taking a GLP-1 medication and then ask you to enter your weight and height so they can calculate your BMI
The survodutide comparison is worth noting here too, as survodutide is another glucagon-containing dual agonist that shows strong liver fat effects
47 Another review of Phase III clinical trials reported similar findings and noted that of the long-acting formulations, once-weekly exenatide was shown to cause a greater number of injection-site reactions compared to once-weekly semaglutide and dulaglutide